RCMI@Morgan: Center for Urban Health Disparities Research and Innovation

Information

  • Research Project
  • 10216666
  • ApplicationId
    10216666
  • Core Project Number
    U54MD013376
  • Full Project Number
    3U54MD013376-02S2
  • Serial Number
    013376
  • FOA Number
    PA-18-591
  • Sub Project Id
  • Project Start Date
    7/31/2019 - 5 years ago
  • Project End Date
    2/29/2024 - 10 months ago
  • Program Officer Name
    JONES, NANCY LYNNE
  • Budget Start Date
    9/1/2020 - 4 years ago
  • Budget End Date
    2/28/2021 - 3 years ago
  • Fiscal Year
    2020
  • Support Year
    02
  • Suffix
    S2
  • Award Notice Date
    9/21/2020 - 4 years ago
Organizations

RCMI@Morgan: Center for Urban Health Disparities Research and Innovation

PROJECT SUMMARY Similar to HIV and hepatitis C virus, SARS-CoV-2, the cause of COVID-19, is most devastating to people of health disparity populations (HDP). However, we hypothesize that COVID-19 could cause health disparities among different HDP (i.e. ?disparities within?) and certain circumstances and determinants could contribute to and predict the ?disparities within?. Our ongoing partnerships with a multi-hospital healthcare system and a multisite community health center for the study of HIV/HCV-related health disparities provide an immediate, practical, and pertinent platform to study the impacts of COVID-19 on health outcomes and healthcare access and utilization among people of various HDP. The hospitals of the healthcare system and the clinics of the community health center are situated in urban, suburban, and rural areas with major health disparities. The healthcare system has provided SARS-CoV-2 testing services and treated many hospitalized COVID-19 patients. The community health center provides HIV care to people of racial/ethnic and sexual/gender minorities and other vulnerable populations. We will take advantage of the ongoing partnerships, using a retrospective cohort study design with data from the medical records, to dissect the ?disparities within? caused by COVID-19. First, we will delineate the clinical features and natural history of COVID-19 among the hospitalized patients, and determine the factors associated with COVID-19 pathogenesis, disease severity, and treatment effectiveness. We also aim to establish novel, unique, and tailored clinical ?scoring? systems/models that can be used to predict COVID-19 outcomes and severity in patients of different HDP. Second, we will analyze the trends in and characteristics of the SARS-CoV-2 testing and assess whether people of the HDP were underrepresented in the testing. We will also analyze the factors associated with SARS-CoV-2 positivity among those tested. For those who tested positive, we will assess their participation/engagement in the COVID-19 cascade of care and determine the factors associated with attending or missing each of the stages in the care cascade. Next, we will assess the HIV continuum of care during the COVID-19 lockdown, analyzing the trends and factors associated with missing appointments, labs, and/or prescriptions as well as the utilization of telehealth. We will also examine the HIV-related health outcomes among those who continued care during the lockdown. Finally, we will perform questionnaire surveys or interviews to assess the experiences and perceptions of (1) COVID-19 patient care from the frontline healthcare workforce and (2) the pros and cons of telehealth in HIV care from the HIV patients and care providers. We will also evaluate how the COVID-19 pandemic has changed/shaped the perception and career/specialty choice of the medical residents, interns, and students. The results from this project will help reduce the health disparities caused by COVID-19 among the HDP. PROJECT SUMMARY

IC Name
National Institute on Minority Health and Health Disparities
  • Activity
    U54
  • Administering IC
    MD
  • Application Type
    3
  • Direct Cost Amount
    125000
  • Indirect Cost Amount
    63750
  • Total Cost
    188750
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    307
  • Ed Inst. Type
    SCHOOLS OF ARTS AND SCIENCES
  • Funding ICs
    NIMHD:188750\
  • Funding Mechanism
    RESEARCH CENTERS
  • Study Section
  • Study Section Name
  • Organization Name
    MORGAN STATE UNIVERSITY
  • Organization Department
    CHEMISTRY
  • Organization DUNS
    879941318
  • Organization City
    BALTIMORE
  • Organization State
    MD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    212510001
  • Organization District
    UNITED STATES